Progress in the diagnosis and treatment of combined hepatocellular-cholangiocarcinoma

李阳,杨龙,张雅敏
DOI: https://doi.org/10.3760/cma.j.cn113884-20190425-00136
2020-01-01
Abstract:Combined hepatocellular-cholangiocarcinoma is a rare and aggressive primary liver malignant tumor with significant histological and biological heterogeneity. It has worse survival than either hepatocellular carcinoma or cholangiocarcinoma and because it’s difficultly to be diagnosed. Understanding the genetic and molecular phenotypes of combined hepatocellular-cholangiocarcinoma will help us to identify the pathogenesis and develop new treatment strategies. This article reviewed the recent research progress on the diagnosis and treatment of combined hepatocellular-cholangiocarcinoma, and explored its characteristics that are different from hepatocellular carcinoma and intrahepatic cholangiocarcinoma in pathology, genetics, clinical manifestations, diagnosis, and treatment, and looks forward to its future research.
What problem does this paper attempt to address?